About: Dactinomycin     Goto   Sponge   Distinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Dactinomycin
rdfs:subClassOf
Concept_In_Subset
Semantic_Type
  • Amino Acid, Peptide, or Protein
  • Antibiotic
Preferred_Name
  • Dactinomycin
NSC_Code
  • 3053
UMLS_CUI
  • C0010934
CAS_Registry
  • 50-76-0
Accepted_Therapeutic_Use_For
  • Wilms' tumor; rhabdomyosarcoma; Ewing's sarcoma; testicular cancer; gestational trophoblastic neoplasia; choriocarcinoma; melanoma; neuroblastoma; retinoblastoma; uterine sarcomas; Kaposi's sarcoma; sarcoma botryoides; soft tissue sarcoma.
In_Clinical_Trial_For
  • unresectable regional melanoma; unresectable soft tissue sarcoma; childhood fibrosarcoma; leukemia; lymphoma; relapsed or refractory clear cell sarcoma of the kidney; malignant mesenchymal tumors
  • Gestational trophoblastic neoplasia; hydatidiform mole; uterine choriocarcinoma; Ewing's sarcoma; rhabdomyosarcoma; Wilm's Tumor
FDA_UNII_Code
  • 1CC1JFE158
Contributing_Source
  • FDA
ALT_DEFINITION
  • An anticancer drug that is a type of antitumor antibiotic.NCI-GLOSS
PDQ_Open_Trial_Search_ID
  • 39675
PDQ_Closed_Trial_Search_ID
  • 39675
Chemical_Formula
  • C62H86N12O16
Legacy_Concept_Name
  • Dactinomycin
CHEBI_ID
  • CHEBI:27666
FULL_SYN
  • DACTINOMYCINPTFDA1CC1JFE158
  • ACTINOMYCIN DSYDTPNSC0003053
  • DactinomycinPTNCI
  • 2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3SNNCI
  • Actinomycin DSYNCI
  • DactinomycineSYNCI
  • Actinomycin-[thr-val-pro-sar-meval]SYNCI
  • Actinomycin C1SYNCI
  • Actinomycin I1SYNCI
  • Actinomycin IVSYNCI
  • MeractinomycinSYNCI
  • Actinomycin IVSYDTPNSC0003053
  • dactinomycinPTNCI-GLOSSCDR0000045237
  • Actinomycin X 1SYNCI
  • Lyovac CosmegenFBNCI
  • MeractinomycinSYDTPNSC0003053
  • DACTABNCI
  • Actinomycin X 1SYDTPNSC0003053
  • DactinomycinPTDCP00417
  • Actinomycin A IVSYNCI
  • Lyovac cosmegenSYDTPNSC0003053
  • CosmegenSYDTPNSC0003053
  • CosmegenBRNCI
DEFINITION
  • A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus. Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04)NCI
code
  • C412
is someValuesFrom of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software